Format

Send to

Choose Destination
See comment in PubMed Commons below
Rheum Dis Clin North Am. 2012 Aug;38(3):569-82. doi: 10.1016/j.rdc.2012.08.012. Epub 2012 Sep 13.

Pathophysiology and role of the gastrointestinal system in spondyloarthritides.

Author information

1
Department of Rheumatology, Ghent University Hospital, Ghent, Belgium.

Abstract

Inflammatory bowel disease (IBD) is a well-known extra-articular manifestation in spondyloarthritis (SpA); about 6.5% of patients with ankylosing spondylitis develop IBD during the course of the disease. The pathogenesis of both SpA and IBD is considered to be the result of a complex interplay between the host (genetic predisposition), the immune system and environmental factors, notably microorganisms, leading to a disturbed immune system and chronic inflammation. Over the past decade, the role of tumor necrosis factor inhibition (infliximab, etanercept, adalimumab, golimumab) in improving signs and symptoms and overall quality of life has been well documented in various forms of SpA. Future research will clarify the role of other potential targets.

PMID:
23083756
DOI:
10.1016/j.rdc.2012.08.012
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center